APO RESEARCH · REPORT
Rapid Influenza Diagnostic Test (RIDT)
Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
Product & engineering
Understand the product.
Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
Selected research
Industry Research
Rapid Influenza Diagnostic Test (RIDT) Industry Research Report 2026
Market perspective
Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
Americas is the largest Rapid Influenza Diagnostic Test (RIDT) market with about 58% market share. Europe is follower, accounting for about 25% market share.
The key players are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy etc. Top 3 companies occupied about 49% market share.
Read the full market overview
Report Scope
This report quantifies the global Rapid Influenza Diagnostic Test (RIDT) market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Rapid Influenza Diagnostic Test (RIDT).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Rapid Influenza Diagnostic Test (RIDT) Market by Company
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy
Rapid Influenza Diagnostic Test (RIDT) Segment by Type
Digital RIDTs
Conventional RIDT
Rapid Influenza Diagnostic Test (RIDT) Segment by Application
Hospitals
POCT
Others
Rapid Influenza Diagnostic Test (RIDT) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rapid Influenza Diagnostic Test (RIDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rapid Influenza Diagnostic Test (RIDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rapid Influenza Diagnostic Test (RIDT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Rapid Influenza Diagnostic Test (RIDT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Digital RIDTs
- Conventional RIDT
Applications
- Hospitals
- POCT
- Others
Companies covered
- BD
- Abbot (Alere)
- Quidel
- Roche
- Thermo Fisher Scientific
- Meridian Bioscience
- Analytik Jena
- Princeton BioMeditech Corporation
- BioMerieux
- Sekisui Diagnostics
- Response Biomedical
- SA Scientific
- DiaSorin (Focus Diagnostics)
- Wondfo
- Beijing Wantai Biological Pharmacy
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Rapid Influenza Diagnostic Test (RIDT) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Digital RIDTs
- 2.2.3 Conventional RIDT
- 2.3 Rapid Influenza Diagnostic Test (RIDT) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 POCT
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Rapid Influenza Diagnostic Test (RIDT) Breakdown Data by Type
- 3.1 Global Rapid Influenza Diagnostic Test (RIDT) Historic Market Size by Type (2021-2026)
- 3.2 Global Rapid Influenza Diagnostic Test (RIDT) Forecasted Market Size by Type (2027-2032)
4 Rapid Influenza Diagnostic Test (RIDT) Breakdown Data by Application
- 4.1 Global Rapid Influenza Diagnostic Test (RIDT) Historic Market Size by Application (2021-2026)
- 4.2 Global Rapid Influenza Diagnostic Test (RIDT) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Perspective (2021-2032)
- 5.2 Global Rapid Influenza Diagnostic Test (RIDT) Growth Trends by Region
- 5.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Rapid Influenza Diagnostic Test (RIDT) Historic Market Size by Region (2021-2026)
- 5.2.3 Rapid Influenza Diagnostic Test (RIDT) Forecasted Market Size by Region (2027-2032)
- 5.3 Rapid Influenza Diagnostic Test (RIDT) Market Dynamics
- 5.3.1 Rapid Influenza Diagnostic Test (RIDT) Industry Trends
- 5.3.2 Rapid Influenza Diagnostic Test (RIDT) Market Drivers
- 5.3.3 Rapid Influenza Diagnostic Test (RIDT) Market Challenges
- 5.3.4 Rapid Influenza Diagnostic Test (RIDT) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Rapid Influenza Diagnostic Test (RIDT) Players by Revenue
- 6.1.1 Global Top Rapid Influenza Diagnostic Test (RIDT) Players by Revenue (2021-2026)
- 6.1.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Players (2021-2026)
- 6.2 Global Rapid Influenza Diagnostic Test (RIDT) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Rapid Influenza Diagnostic Test (RIDT) Head Office and Area Served
- 6.4 Global Rapid Influenza Diagnostic Test (RIDT) Players, Product Type & Application
- 6.5 Global Rapid Influenza Diagnostic Test (RIDT) Manufacturers Established Date
- 6.6 Global Rapid Influenza Diagnostic Test (RIDT) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Rapid Influenza Diagnostic Test (RIDT) Market Size (2021-2032)
- 7.2 North America Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026)
- 7.4 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size (2021-2032)
- 8.2 Europe Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026)
- 8.4 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size (2021-2032)
- 9.2 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Rapid Influenza Diagnostic Test (RIDT) Market Size (2021-2032)
- 10.2 South America Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026)
- 10.4 South America Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size (2021-2032)
- 11.2 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BD
- 12.1.1 BD Company Information
- 12.1.2 BD Business Overview
- 12.1.3 BD Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.1.4 BD Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.1.5 BD Recent Developments
- 12.2 Abbot (Alere)
- 12.2.1 Abbot (Alere) Company Information
- 12.2.2 Abbot (Alere) Business Overview
- 12.2.3 Abbot (Alere) Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.2.4 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.2.5 Abbot (Alere) Recent Developments
- 12.3 Quidel
- 12.3.1 Quidel Company Information
- 12.3.2 Quidel Business Overview
- 12.3.3 Quidel Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.3.4 Quidel Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.3.5 Quidel Recent Developments
- 12.4 Roche
- 12.4.1 Roche Company Information
- 12.4.2 Roche Business Overview
- 12.4.3 Roche Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.4.4 Roche Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.4.5 Roche Recent Developments
- 12.5 Thermo Fisher Scientific
- 12.5.1 Thermo Fisher Scientific Company Information
- 12.5.2 Thermo Fisher Scientific Business Overview
- 12.5.3 Thermo Fisher Scientific Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.5.4 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.5.5 Thermo Fisher Scientific Recent Developments
- 12.6 Meridian Bioscience
- 12.6.1 Meridian Bioscience Company Information
- 12.6.2 Meridian Bioscience Business Overview
- 12.6.3 Meridian Bioscience Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.6.4 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.6.5 Meridian Bioscience Recent Developments
- 12.7 Analytik Jena
- 12.7.1 Analytik Jena Company Information
- 12.7.2 Analytik Jena Business Overview
- 12.7.3 Analytik Jena Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.7.4 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.7.5 Analytik Jena Recent Developments
- 12.8 Princeton BioMeditech Corporation
- 12.8.1 Princeton BioMeditech Corporation Company Information
- 12.8.2 Princeton BioMeditech Corporation Business Overview
- 12.8.3 Princeton BioMeditech Corporation Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.8.4 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.8.5 Princeton BioMeditech Corporation Recent Developments
- 12.9 BioMerieux
- 12.9.1 BioMerieux Company Information
- 12.9.2 BioMerieux Business Overview
- 12.9.3 BioMerieux Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.9.4 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.9.5 BioMerieux Recent Developments
- 12.10 Sekisui Diagnostics
- 12.10.1 Sekisui Diagnostics Company Information
- 12.10.2 Sekisui Diagnostics Business Overview
- 12.10.3 Sekisui Diagnostics Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.10.4 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.10.5 Sekisui Diagnostics Recent Developments
- 12.11 Response Biomedical
- 12.11.1 Response Biomedical Company Information
- 12.11.2 Response Biomedical Business Overview
- 12.11.3 Response Biomedical Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.11.4 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.11.5 Response Biomedical Recent Developments
- 12.12 SA Scientific
- 12.12.1 SA Scientific Company Information
- 12.12.2 SA Scientific Business Overview
- 12.12.3 SA Scientific Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.12.4 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.12.5 SA Scientific Recent Developments
- 12.13 DiaSorin (Focus Diagnostics)
- 12.13.1 DiaSorin (Focus Diagnostics) Company Information
- 12.13.2 DiaSorin (Focus Diagnostics) Business Overview
- 12.13.3 DiaSorin (Focus Diagnostics) Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.13.4 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.13.5 DiaSorin (Focus Diagnostics) Recent Developments
- 12.14 Wondfo
- 12.14.1 Wondfo Company Information
- 12.14.2 Wondfo Business Overview
- 12.14.3 Wondfo Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.14.4 Wondfo Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.14.5 Wondfo Recent Developments
- 12.15 Beijing Wantai Biological Pharmacy
- 12.15.1 Beijing Wantai Biological Pharmacy Company Information
- 12.15.2 Beijing Wantai Biological Pharmacy Business Overview
- 12.15.3 Beijing Wantai Biological Pharmacy Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2021-2026)
- 12.15.4 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
- 12.15.5 Beijing Wantai Biological Pharmacy Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst